2m 2m 2m 2m 2m 2m 2m
KYMERA THERAP (KYMR)
NASDAQ
$119.59-$0.21 (-0.18%)
Price as of Aug 21, 2026 7:30 PM EDT- $10.0BMarket Cap
- 171.66%1-Year Change
- BiotechnologyIndustry
KYMERA THERAP (KYMR)
$119.59-$0.21 (-0.18%)
KYMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $119.80 | ||
Change | -$1.70 (-1.40%) | ||
Open | $122.87 | ||
High | $125.71 | ||
Low | $119.77 | ||
Previous Close | $121.50 | ||
Volume | 503,430 | ||
30-Day Average Volume | 650,718 | ||
1-Week Change | 2.05% | ||
1-Month Change | 5.67% | ||
1-Year Change | 171.66% | ||
3-Year Change | 489.28% | ||
5-Year Change | 123.17% | ||
Fundamentals | |||
Shares Outstanding | 83.2M | ||
Total Assets | $1.6B | ||
Market Cap | $10.0B | ||
Enterprise Value | $9.8B | ||
Period: QTR TTM FY | |||
Revenue | $65.0M | ||
Net Income | -$61.2M | ||
Free Cash Flow | -$54.5M | ||
EBIT | -$61.1M | ||
EBITDA | -$59.1M | ||
Net Working Capital | $665.9M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -166 | ||
Enterprise Value/Revenue | 151 | ||
P/B | 7 | ||
P/E | -193 | ||
PEG | -15 | ||
Price/Free Cash Flow | -183 | ||
Price/Operating Cash Flow | -184 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue